Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin vs Ivermectin for Onchocerciasis in DRC
NCT03876262Phase 3Active, not recruiting
- Sponsor
- Medicines Development for Global Health
- Start
- May 2021
- Primary completion
- Jul 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of moxidectin in onchocerciasis, sponsored by Medicines Development for Global Health. Started May 2021; status: active, not recruiting.
02
Drugs
moxidectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT03876262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03876262.